News coverage about Cooper Companies (NYSE:COO) has been trending somewhat positive recently, Accern Sentiment Analysis reports. The research firm identifies positive and negative press coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Cooper Companies earned a daily sentiment score of 0.24 on Accern’s scale. Accern also gave press coverage about the medical device company an impact score of 46.3313770115447 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Here are some of the news stories that may have impacted Accern Sentiment’s analysis:

Shares of Cooper Companies (NYSE:COO) traded up $3.97 during trading hours on Wednesday, reaching $229.79. The company’s stock had a trading volume of 323,975 shares, compared to its average volume of 495,741. The company has a market cap of $11,116.09, a P/E ratio of 30.56, a PEG ratio of 1.83 and a beta of 0.57. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.41 and a quick ratio of 1.26. Cooper Companies has a 52-week low of $189.41 and a 52-week high of $256.39.

Cooper Companies (NYSE:COO) last announced its quarterly earnings data on Thursday, December 7th. The medical device company reported $2.65 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.64 by $0.01. The firm had revenue of $561.50 million during the quarter, compared to the consensus estimate of $558.86 million. Cooper Companies had a return on equity of 16.02% and a net margin of 17.43%. The business’s revenue for the quarter was up 8.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.28 EPS. sell-side analysts forecast that Cooper Companies will post 11.55 EPS for the current year.

The firm also recently disclosed a semiannual dividend, which was paid on Friday, February 9th. Shareholders of record on Tuesday, January 23rd were paid a $0.03 dividend. The ex-dividend date was Monday, January 22nd. This represents a yield of 0.03%. Cooper Companies’s dividend payout ratio (DPR) is presently 0.80%.

Several equities research analysts recently issued reports on COO shares. Zacks Investment Research downgraded Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, November 1st. Stifel Nicolaus reiterated a “buy” rating and set a $265.00 price target (down previously from $275.00) on shares of Cooper Companies in a report on Friday, December 8th. Cleveland Research downgraded Cooper Companies from a “buy” rating to a “hold” rating in a report on Friday, February 9th. Oppenheimer set a $250.00 price target on Cooper Companies and gave the stock a “hold” rating in a report on Friday, December 8th. Finally, Raymond James Financial reiterated a “buy” rating and set a $265.00 price target on shares of Cooper Companies in a report on Monday, December 4th. Eight research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Cooper Companies has a consensus rating of “Hold” and a consensus target price of $259.70.

In other Cooper Companies news, CEO Robert S. Weiss sold 32,500 shares of the company’s stock in a transaction on Monday, December 18th. The stock was sold at an average price of $224.70, for a total value of $7,302,750.00. Following the completion of the transaction, the chief executive officer now owns 119,111 shares in the company, valued at approximately $26,764,241.70. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Allan E. Rubenstein sold 6,450 shares of the company’s stock in a transaction on Friday, January 12th. The shares were sold at an average price of $228.79, for a total value of $1,475,695.50. Following the completion of the transaction, the director now owns 8,628 shares of the company’s stock, valued at approximately $1,974,000.12. The disclosure for this sale can be found here. Insiders sold a total of 54,385 shares of company stock valued at $12,289,463 in the last 90 days. Corporate insiders own 1.60% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This piece was reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this piece on another domain, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this piece can be read at https://theolympiareport.com/2018/02/14/cooper-companies-coo-receiving-somewhat-favorable-press-coverage-study-shows.html.

About Cooper Companies

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Insider Buying and Selling by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.